{"cluster": 0, "subcluster": 3, "abstract_summ": "During the initial pandemic wave of COVID-19, apart from common presenting symptoms (cough, fever, and fatigue), many countries have reported a sudden increase in the number of smell and taste dysfunction patients.We also discuss the possibility of using \"smell and taste loss\" as a screening tool for COVID-19 and treatment options in the post-SARS-CoV-2 infectious olfactory loss.However, loss of smell could be presented in COVID-19 patients without other rhinologic symptoms or significant nasal inflammation.The device is designed to work with a mobile app that can trigger selected smell or combinations and further can be programmed to give standard or customised smell tests.This review aims to provide a brief overview of recent evidence for epidemiology, pathological mechanisms for the smell, and taste dysfunction in SARS-CoV-2 infected patients.", "title_summ": "Smell and taste dysfunction in patients with SARS-CoV-2 infection: A review of epidemiology, pathogenesis, prognosis, and treatment options.Olfactory Device for Large Scale Pre-screening for COVID-19Altered Taste in Patients with COVID\u201019: The Potential Role of Salivary Glands", "title_abstract_phrases": "During the initial pandemic wave of COVID-19, apart from common presenting symptoms (cough, fever, and fatigue), many countries have reported a sudden increase in the number of smell and taste dysfunction patients.We also discuss the possibility of using \"smell and taste loss\" as a screening tool for COVID-19 and treatment options in the post-SARS-CoV-2 infectious olfactory loss.However, loss of smell could be presented in COVID-19 patients without other rhinologic symptoms or significant nasal inflammation.Smell and taste dysfunction in patients with SARS-CoV-2 infection: A review of epidemiology, pathogenesis, prognosis, and treatment options.This review aims to provide a brief overview of recent evidence for epidemiology, pathological mechanisms for the smell, and taste dysfunction in SARS-CoV-2 infected patients."}